Cromos Pharma’s Monika David Shares Key Insights at Hungarian Clinical Trials Conference

On September 19-20, 2024, the ninth annual conference of the Hungarian Clinical Trial Management Society took place in Siófok, Hungary. The event brought together industry professionals to discuss significant developments in clinical research, including the Clinical Trials Information System (CTIS), new regulations, and the evolving role of institutional pharmacies in clinical trials. 

Monika David, EU Regulatory Lead at Cromos Pharma, presented on “EU CTR: Results and Experiences of the Last Year,” sharing insights on recent changes and challenges faced by trial organizers. She also participated in discussions with representatives from Hungarian authorities and ethics committees, addressing key issues in clinical trial management.

The conference concluded with a review of key outcomes, such as the ongoing challenges with the CTIS system, the success of accelerated Phase I approvals in Hungary, and the strengthened collaboration between regulators, ethics committees, and sponsors. These developments have made Hungary an increasingly attractive location for conducting clinical trials.

At Cromos Pharma, we’ve become highly proficient in navigating the complexities of CTR submissions, thanks to our exceptional regulatory team led by experts like Monika. Our deep understanding of the evolving regulatory landscape and hands-on experience with the CTR process have positioned us as a trusted partner for biopharma companies looking to streamline their trial approvals.

We invite biopharma companies to tap into our regulatory expertise to ensure seamless, efficient, and compliant submissions, helping them bring innovative treatments to market faster. Let Cromos Pharma’s regulatory excellence drive your clinical trial success!